• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Arresto BioSciences

edit

Arresto Biosciences, Inc., a biotechnology company, develops medicines to treat cancer and fibrotic diseases by targeting molecules from the extracellular matrix. The company was incorporated in 2007 and is based in Palo Alto, California.

Recent Milestones

edit

• 
  Arresto BioSciences was acquired by Gilead Sciences for $225M. (12/20/10)
  Posted 12/20/10 at 9:05pm via dowjones.com
• 
  Arresto BioSciences added Peter Van Vlasselaer as President and CEO.
  Posted 12/20/10 at 9:03pm

Videos

Screenshots

edit

Sources

1. Gilead Sciences To Acquire Arresto BioSciences For $225M Cash (fis.dowjones.com) [edit]